- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
Search Results
156 results for bivv
Only Have $50 to Invest? Then Buy These 3 Stocks Now.
It doesn’t take money to make money anymore, you just have to find the right stocks to buy and then hold for the long-term.
Bioverativ’s (BIVV) Quant Score Gives it Buy
Bioverativ Inc (NULL:BIVV) is ranked as a Buy using Louis Navellier’s Portfolio Grader stock evaluator, which incorporates his investing methodology. BIVV has been downgraded from…
Bioverativ Inc Stock Gets 64% Premium in Acquisition by Sanofi
Bioverativ (BIVV) is being acquired for $11.6 billion in cash. That puts a 64% premium on BIVV stock and signal a new phase in biotech…
It’s a Scratch, Not a Ding for Biogen Inc (BIIB) Stock
It hasn’t been a value-add just yet for Biogen stock, but a spin-off of Bioverativ, should unlock plenty of value for both businesses.
Biotech M&A: Sanofi SA (ADR) Inks 2nd Multi-Billion Dollar Deal in a Week
Sanofi (SNY) inks second multi-dollar deal this month. Since the earlier deal last Monday, SNY stock gained 2.6% in a week.
BIVI Stock Earnings: BioVie Beats EPS for Q3 2024
BIVI stock results show that BioVie beat analyst estimates for earnings per share the third quarter of 2024.
5 Biotech and Pharmaceutical Stocks Going Bonkers
These biotech and pharmaceutical stocks are soaring insanely high right now. Here’s what investors should know about each of these hot stocks to buy.
Is Sanofi’s Bioverative Inc Buyout Just the Start?
Bioverativ and Juno Therapeutics both drew buyout bids as drug companies seek to use CAR-T therapy against cancer profitably.
Why Biogen Inc (BIIB) Stock Is a Solid Long-Term Bet
Biogen’s run over the last five years has definitely been impressive, but growth is slowing. However, BIIB stock still looks like a good bet.
Why Investors Should Stay Long Eli Lilly and Co Stock
LLY stock had a sudden drop on Jan. 22, but Eli Lilly and Co recovered the bulk of its losses, which means bulls can stay…
Why Is BioVie (BIVI) Stock Down 41% Today?
BioVie stock is falling on Monday after the company announced pricing for $21 million shares of BIVI stock in a public offering.
Why Is BioVie (BIVI) Stock Up 100% Today?
BioVie stock is rising higher with heavy trading of BIVI following positive clinical trial data for its Alzheimer’s and Parkinson’s drug.
Why Is BioVie (BIVI) Stock Down 63% Today?
BioVie stock is falling after its Phase 3 clinical trial of its Alzheimer’s treatment candidate failed to show statistical significance.
iShares S&P 500 Index (ETF) (IVV): The Quick Guide to IVV
The iShares Core S&P 500 ETF (IVV) charges minuscule fees for basic, broad market tracking. Is IVV right for you?
BioVie (BIVI) Stock Pops on Positive Alzheimer’s Trial Results
The buying pressure is building with BIVI stock today as BioVie releases encouraging clinical trial results for a hard-to-treat ailment.
The 3 Best ETFs to Buy on Future Dips
Market corrections can be an opportune time to enter into positions. We highlight three of the best ETFs to buy now or on future dips.
The 7 ETFs to Buy for the Perfect Portfolio
These seven ETFs to buy provide investors with an easily manageable portfolio that delivers good risk-adjusted returns over the long haul.
Why Is Farfetch (FTCH) Stock Down 50% Today?
Farfetch stock is falling on Wednesday as shares of FTCH have been volatile alongside going private reports, delayed earnings and more.
1 – 7 of 156 results
